EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES

EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES

Background. Blocking of B lymphocytes producing autoantibodies in systemic lupus erythematosus (SLE) may be an effective strategy for pathogenetic treatment, including in children. Objective: Our aim was to assess the efficacy and safety of rituximab treatment (chimeric monoclonal antibodies to CD20...

Full description

Bibliographic Details
Main Authors: Ekaterina I. Alexeeva, Rina V. Denisova, Saniya I. Valieva, Tatyana M. Bzarova, Tatyana V. Sleptsova, Alexandra M. Chomakhidze, Kseniya B. Isayeva, Evgeniya G. Chystyakova, Elena L. Semikina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2016-11-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
children
systemic lupus erythematosus
severe course
refractoriness
rituximab
Online Access:https://vsp.spr-journal.ru/jour/article/view/1674

Internet

https://vsp.spr-journal.ru/jour/article/view/1674

Similar Items